These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22575581)

  • 1. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?
    Cunnane SC; Chouinard-Watkins R; Castellano CA; Barberger-Gateau P
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):61-70. PubMed ID: 22575581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease.
    Plourde M; Fortier M; Vandal M; Tremblay-Mercier J; Freemantle E; Bégin M; Pifferi F; Cunnane SC
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):301-8. PubMed ID: 18036804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline.
    Hennebelle M; Plourde M; Chouinard-Watkins R; Castellano CA; Barberger-Gateau P; Cunnane SC
    Proc Nutr Soc; 2014 Feb; 73(1):80-6. PubMed ID: 24103099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fish, docosahexaenoic acid and Alzheimer's disease.
    Cunnane SC; Plourde M; Pifferi F; Bégin M; Féart C; Barberger-Gateau P
    Prog Lipid Res; 2009 Sep; 48(5):239-56. PubMed ID: 19362576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.
    Belkouch M; Hachem M; Elgot A; Lo Van A; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
    J Nutr Biochem; 2016 Dec; 38():1-11. PubMed ID: 27825512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
    Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
    J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and up-regulates cytoskeletal protein expression.
    Wang PY; Chen JJ; Su HM
    J Nutr Biochem; 2010 Apr; 21(4):345-50. PubMed ID: 19423322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects.
    Florent-Béchard S; Malaplate-Armand C; Koziel V; Kriem B; Olivier JL; Pillot T; Oster T
    J Neurol Sci; 2007 Nov; 262(1-2):27-36. PubMed ID: 17681547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance.
    Su HM
    J Nutr Biochem; 2010 May; 21(5):364-73. PubMed ID: 20233652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?
    Pan Y; Khalil H; Nicolazzo JA
    Curr Clin Pharmacol; 2015; 10(3):222-41. PubMed ID: 26338174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE ε4 allele.
    Chouinard-Watkins R; Rioux-Perreault C; Fortier M; Tremblay-Mercier J; Zhang Y; Lawrence P; Vohl MC; Perron P; Lorrain D; Brenna JT; Cunnane SC; Plourde M
    Br J Nutr; 2013 Nov; 110(10):1751-9. PubMed ID: 23631810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies.
    Calon F; Cole G
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):287-93. PubMed ID: 18037281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish.
    Pauwels EK; Volterrani D; Mariani G; Kairemo K
    Drug News Perspect; 2009 May; 22(4):205-13. PubMed ID: 19536365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ω-3 fatty acids in the prevention of cognitive decline in humans.
    Cederholm T; Salem N; Palmblad J
    Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model.
    Cole GM; Frautschy SA
    Nutr Health; 2006; 18(3):249-59. PubMed ID: 17180870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria.
    Eckert GP; Lipka U; Muller WE
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):105-14. PubMed ID: 22727983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inadequate supply of vitamins and DHA in the elderly: implications for brain aging and Alzheimer-type dementia.
    Mohajeri MH; Troesch B; Weber P
    Nutrition; 2015 Feb; 31(2):261-75. PubMed ID: 25592004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline.
    Nock TG; Chouinard-Watkins R; Plourde M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt A):1068-1078. PubMed ID: 28733268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of DHA status.
    Kuratko CN; Salem N
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):111-8. PubMed ID: 19545987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.